GB202020285D0 - Treatment od disorders associated with loww BH4 bioavailablility - Google Patents

Treatment od disorders associated with loww BH4 bioavailablility

Info

Publication number
GB202020285D0
GB202020285D0 GBGB2020285.9A GB202020285A GB202020285D0 GB 202020285 D0 GB202020285 D0 GB 202020285D0 GB 202020285 A GB202020285 A GB 202020285A GB 202020285 D0 GB202020285 D0 GB 202020285D0
Authority
GB
United Kingdom
Prior art keywords
loww
bioavailablility
treatment
disorders associated
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2020285.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB2020285.9A priority Critical patent/GB202020285D0/en
Publication of GB202020285D0 publication Critical patent/GB202020285D0/en
Priority to MX2023007167A priority patent/MX2023007167A/en
Priority to JP2023537676A priority patent/JP2024502252A/en
Priority to KR1020237024218A priority patent/KR20230124967A/en
Priority to IL303773A priority patent/IL303773A/en
Priority to PCT/GB2021/053382 priority patent/WO2022136851A1/en
Priority to AU2021406035A priority patent/AU2021406035A1/en
Priority to CA3202619A priority patent/CA3202619A1/en
Priority to EP21839631.5A priority patent/EP4262806A1/en
Priority to CL2023001821A priority patent/CL2023001821A1/en
Priority to CONC2023/0008648A priority patent/CO2023008648A2/en
Ceased legal-status Critical Current

Links

GBGB2020285.9A 2020-12-21 2020-12-21 Treatment od disorders associated with loww BH4 bioavailablility Ceased GB202020285D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB2020285.9A GB202020285D0 (en) 2020-12-21 2020-12-21 Treatment od disorders associated with loww BH4 bioavailablility
EP21839631.5A EP4262806A1 (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low bh4 bioavailability
IL303773A IL303773A (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low bh4 bioavailability
JP2023537676A JP2024502252A (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low BH4 bioavailability
KR1020237024218A KR20230124967A (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low BH4 bioavailability
MX2023007167A MX2023007167A (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low bh4 bioavailability.
PCT/GB2021/053382 WO2022136851A1 (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low bh4 bioavailability
AU2021406035A AU2021406035A1 (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low bh4 bioavailability
CA3202619A CA3202619A1 (en) 2020-12-21 2021-12-21 Treatment of disorders associated with low bh4 bioavailability
CL2023001821A CL2023001821A1 (en) 2020-12-21 2023-06-19 Treatment of disorders associated with low bioavailability of bh4.
CONC2023/0008648A CO2023008648A2 (en) 2020-12-21 2023-06-29 Treatment of disorders associated with low bioavailability of bh4

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2020285.9A GB202020285D0 (en) 2020-12-21 2020-12-21 Treatment od disorders associated with loww BH4 bioavailablility

Publications (1)

Publication Number Publication Date
GB202020285D0 true GB202020285D0 (en) 2021-02-03

Family

ID=74221139

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2020285.9A Ceased GB202020285D0 (en) 2020-12-21 2020-12-21 Treatment od disorders associated with loww BH4 bioavailablility

Country Status (1)

Country Link
GB (1) GB202020285D0 (en)

Similar Documents

Publication Publication Date Title
MX2021009830A (en) Methods for the treatment of abnormal involuntary movement disorders.
MY192917A (en) Compositions and methods of use for treating metabolic disorders
IL291272A (en) Neuromodulation of the glossopharyngeal nerve to improve sleep disordered breathing
PH12016501802B1 (en) Absorbent article
EP2485799A4 (en) Extracranial implantable devices, systems and methods for the treatment of neurological disorders
SG11202011018PA (en) 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization
GB201907283D0 (en) Use of cannabidiol in the treatment of epileptic spams
SG11202011010YA (en) 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization
SG11202100092QA (en) USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONRIAL DISORDERS
MX354598B (en) Use of neuregulin to treat peripheral nerve injury.
IL275499A (en) Methods of treating metabolic disorders with fgf21 variants
EP3890753A4 (en) Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh1 activity
GB201914034D0 (en) Treatment of neurological disorders
GB202020285D0 (en) Treatment od disorders associated with loww BH4 bioavailablility
ZA202205546B (en) Methods for providing continuous therapy against pnag comprising microbes
IL285304A (en) Methods for treating symptoms and disorders associated with lysosomal storage diseases
GB202108231D0 (en) Treatment of disorders associated with low bh4 bioavaliability
IL309392A (en) Retinal disorders
IL309393A (en) Retinal disorders
GB202108756D0 (en) Retinal disorders
GB202108759D0 (en) Retinal disorders
GB202108760D0 (en) Retinal disorders
GB202204231D0 (en) Retinal Disorders
GB202204234D0 (en) Retinal Disorders
GB202204230D0 (en) Retinal Disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)